Evaxion to announce business update and second quarter 2025 financial results on august 14, 2025

Copenhagen, denmark, august 11, 2025 - evaxion a/s (nasdaq: evax) (“evaxion”), a clinical-stage techbio company specializing in developing ai-immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on thursday august 14, 2025, before opening of the nasdaq cm.
EVAX Ratings Summary
EVAX Quant Ranking